Osmetech Names New Chairman, Olex Joins RainDance, Peden to Head Znomics' European Operations, and Others | GenomeWeb
NEW YORK (GenomeWeb News) - Osmetech has named Daryl Faulkner to be non-executive chairman. The company’s current chairman, Gordon Hall, will step down but will remain on the board as a non-executive director.
 
Faulkner recently was president and CEO of Digene, and he was a senior VP and GM for strategic business and international operations at Invitrogen.
 
Osmetech also said that Bruce Huebner has retired from the company and has left his position as a director.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.